InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
16,871.60
(
-0.77%
)
Dow Jones
38,460.92
(
-0.11%
)
Brent Oil
87.22
(
-0.39%
)
Bitcoin
64,141.88
(
-3.42%
)
Post# of 48
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Steveg

Send PM Follow Ignore
Followers 2
Posts 440
Boards Moderated 0
Alias Born 02/25/2004

Steveg

Re: None

Sunday, 10/24/2004 6:00:58 PM

Sunday, October 24, 2004 6:00:58 PM

Post# of 48
Even a cursory review of the company's press releases lets one know that there is something very significant going on. The company is on the cusp of beneficial joint ventures with other manufacturers, FDA testing, and subsequent product marketing. They have strong patent protection. The company has demonstrated proof of concept for use of their treatment for a number of autoimmune diseases. Phase I testing for high viral load HIV patients is slated to begin. I would advise that interested investors pay close attention, read the press releases, view the SEC filings, and visit the company website (http://www.advancedbiotherapy.com).

Steve
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up